
Harmony Biosciences Posts Strong Q1 2025 Results, Highlights Pipeline Progress and 2025 Outlook
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported robust financial and operational results for the first quarter of 2025, underscoring the company’s continued momentum and strategic focus on advancing its late-stage pipeline while reaffirming full-year revenue guidance. The company achieved a…













